Global Oncolytic Virus Therapy Market Size, Status and Forecast 2027

Table of Contents

Global Oncolytic Virus Therapy Market Size, Status and Forecast 2022
1 Industry Overview of Oncolytic Virus Therapy
1.1 Oncolytic Virus Therapy Market Overview
1.1.1 Oncolytic Virus Therapy Product Scope
1.1.2 Market Status and Outlook
1.2 Global Oncolytic Virus Therapy Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Oncolytic Virus Therapy Market by Type
1.3.1 Onxy-15
1.3.2 RIGVIR
1.3.3 Talimogene laherparepvec (T-VEC)
1.3.4 Reolysin
1.4 Oncolytic Virus Therapy Market by End Users/Application
1.4.1 Lung Cancer
1.4.2 Prostate Cancer
1.4.3 Melanoma
1.4.4 Brain Tumor
1.4.5 Others

2 Global Oncolytic Virus Therapy Competition Analysis by Players
2.1 Oncolytic Virus Therapy Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Crusade Laboratories
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Genelux Corporation
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Oncolytics Biotech
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Oncos Therapeutics
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Jennerex Biotherapeutics
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Lokon Pharma
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Merck
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 MultiVir
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Oncolys BioPharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 BioVex
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Cell Genesys
3.12 PsiOxus Therapeutics

4 Global Oncolytic Virus Therapy Market Size by Type and Application (2012-2017)
4.1 Global Oncolytic Virus Therapy Market Size by Type (2012-2017)
4.2 Global Oncolytic Virus Therapy Market Size by Application (2012-2017)
4.3 Potential Application of Oncolytic Virus Therapy in Future
4.4 Top Consumer/End Users of Oncolytic Virus Therapy

5 United States Oncolytic Virus Therapy Development Status and Outlook
5.1 United States Oncolytic Virus Therapy Market Size (2012-2017)
5.2 United States Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

6 EU Oncolytic Virus Therapy Development Status and Outlook
6.1 EU Oncolytic Virus Therapy Market Size (2012-2017)
6.2 EU Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

7 Japan Oncolytic Virus Therapy Development Status and Outlook
7.1 Japan Oncolytic Virus Therapy Market Size (2012-2017)
7.2 Japan Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

8 China Oncolytic Virus Therapy Development Status and Outlook
8.1 China Oncolytic Virus Therapy Market Size (2012-2017)
8.2 China Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

9 India Oncolytic Virus Therapy Development Status and Outlook
9.1 India Oncolytic Virus Therapy Market Size (2012-2017)
9.2 India Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Oncolytic Virus Therapy Development Status and Outlook
10.1 Southeast Asia Oncolytic Virus Therapy Market Size (2012-2017)
10.2 Southeast Asia Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Oncolytic Virus Therapy Market Size (Value) by Regions (2017-2022)
11.1.1 United States Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
11.1.2 EU Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
11.1.3 Japan Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
11.1.4 China Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
11.1.5 India Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
11.2 Global Oncolytic Virus Therapy Market Size (Value) by Type (2017-2022)
11.3 Global Oncolytic Virus Therapy Market Size by Application (2017-2022)

12 Oncolytic Virus Therapy Market Dynamics
12.1 Oncolytic Virus Therapy Market Opportunities
12.2 Oncolytic Virus Therapy Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Oncolytic Virus Therapy Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Oncolytic Virus Therapy Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source



List of Tables and Figures

Figure Oncolytic Virus Therapy Product Scope
Figure Global Oncolytic Virus Therapy Market Size (Million USD) (2012-2017)
Table Global Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Oncolytic Virus Therapy Market Share by Regions in 2016
Figure United States Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Oncolytic Virus Therapy Market Share by Type in 2016
Figure Onxy-15 Market Size (Million USD) and Growth Rate (2012-2017)
Figure RIGVIR Market Size (Million USD) and Growth Rate (2012-2017)
Figure Talimogene laherparepvec (T-VEC) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Reolysin Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Oncolytic Virus Therapy Market Share by Application in 2016
Table Key Downstream Customer in Lung Cancer
Figure Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate in Lung Cancer (2012-2017)
Table Key Downstream Customer in Prostate Cancer
Figure Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate in Prostate Cancer (2012-2017)
Table Key Downstream Customer in Melanoma
Figure Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate in Melanoma (2012-2017)
Table Key Downstream Customer in Brain Tumor
Figure Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate in Brain Tumor (2012-2017)
Table Key Downstream Customer in Others
Figure Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Oncolytic Virus Therapy Market Size (Million USD) by Players (2016 and 2017)
Figure Oncolytic Virus Therapy Market Size Share by Players in 2016
Figure Oncolytic Virus Therapy Market Size Share by Players in 2017
Table Crusade Laboratories Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of Crusade Laboratories (2012-2017)
Figure Crusade Laboratories Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table Genelux Corporation Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of Genelux Corporation (2012-2017)
Figure Genelux Corporation Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table Oncolytics Biotech Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of Oncolytics Biotech (2012-2017)
Figure Oncolytics Biotech Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table Oncos Therapeutics Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of Oncos Therapeutics (2012-2017)
Figure Oncos Therapeutics Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table Jennerex Biotherapeutics Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of Jennerex Biotherapeutics (2012-2017)
Figure Jennerex Biotherapeutics Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table Lokon Pharma Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of Lokon Pharma (2012-2017)
Figure Lokon Pharma Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table MultiVir Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of MultiVir (2012-2017)
Figure MultiVir Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table Oncolys BioPharma Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of Oncolys BioPharma (2012-2017)
Figure Oncolys BioPharma Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table BioVex Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of BioVex (2012-2017)
Figure BioVex Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table Cell Genesys Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of Cell Genesys (2012-2017)
Figure Cell Genesys Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table PsiOxus Therapeutics Basic Information List
Table Oncolytic Virus Therapy Business Revenue (Million USD) of PsiOxus Therapeutics (2012-2017)
Figure PsiOxus Therapeutics Oncolytic Virus Therapy Business Revenue Market Share in 2016
Table Global Oncolytic Virus Therapy Market Size (Million USD) by Type (2012-2017)
Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2012
Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2013
Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2014
Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2015
Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2016
Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2017
Table Global Oncolytic Virus Therapy Market Size (Million USD) by Application (2012-2017)
Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2012
Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2013
Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2014
Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2015
Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2016
Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Oncolytic Virus Therapy
Figure United States Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
Figure United States Oncolytic Virus Therapy Market Size Share by Players in 2016
Figure United States Oncolytic Virus Therapy Market Size Share by Players in 2017
Figure EU Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
Figure EU Oncolytic Virus Therapy Market Size Share by Players in 2016
Figure EU Oncolytic Virus Therapy Market Size Share by Players in 2017
Figure Japan Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
Figure Japan Oncolytic Virus Therapy Market Size Share by Players in 2016
Figure Japan Oncolytic Virus Therapy Market Size Share by Players in 2017
Figure China Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
Figure China Oncolytic Virus Therapy Market Size Share by Players in 2016
Figure China Oncolytic Virus Therapy Market Size Share by Players in 2017
Figure India Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
Figure India Oncolytic Virus Therapy Market Size Share by Players in 2016
Figure India Oncolytic Virus Therapy Market Size Share by Players in 2017
Figure Southeast Asia Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Oncolytic Virus Therapy Market Size Share by Players in 2016
Figure Southeast Asia Oncolytic Virus Therapy Market Size Share by Players in 2017
Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Regions (2017-2022)
Table Global Oncolytic Virus Therapy Market Size (Million USD) by Regions (2017-2022)
Figure Global Oncolytic Virus Therapy Market Size Share by Regions in 2017
Figure Global Oncolytic Virus Therapy Market Size Share by Regions in 2022
Figure United States Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Oncolytic Virus Therapy Market Size (Million USD) by Type (2017-2022)
Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2017
Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2022
Table Global Oncolytic Virus Therapy Market Size (Million USD) by Application (2017-2022)
Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2017
Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2022